Onglyza 2.5 mg, film-coated tablets

( ARTG ) Add-on combination: ONGLYZA is indicated in patients with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose lowering medicines, when these together with diet and exercise, do not provide a‍‍‍‍‍‍​​​‍​​​​​​dequate glycaemic control (see Clinical Trials and Precautions for available data on different add-on combination therapies).,Initial combination: ONGLYZA is indicated for use as initial combination therapy with metformin, in patients with type 2 diabetes mellitus, to improve glycaemic control as an adjunct to diet and exercise, when dual saxagliptin and metformin therapy is appropriate (i.e. high initial HbA1c levels and poor prospects for response to monotherapy).